Hantavirus lacks the person-to-person transmission efficiency needed for pandemic spread, with CDC and WHO data showing primarily rodent-to-human spillover via aerosolized excreta and only rare, limited clusters from specific strains such as Andes virus. Current epidemiological surveillance through August 2026 reports no sustained chains or exponential case growth that would meet pandemic thresholds, supporting the 96.3% market-implied probability of "No." Trader consensus reflects this biological barrier alongside historical incidence patterns of sporadic, geographically contained infections. A realistic scenario that could shift odds involves an unexpected viral mutation enabling efficient human transmission, though surveillance data indicate such changes remain low-probability within the remaining months of 2026.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया2026 में हंटावायरस महामारी?
हाँ
$17,820,627 वॉल्यूम
$17,820,627 वॉल्यूम
हाँ
$17,820,627 वॉल्यूम
$17,820,627 वॉल्यूम
An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
बाज़ार खुला: May 4, 2026, 10:26 AM ET
Resolver
0x65070BE91...An explicit characterization includes official WHO statements, reports, press briefings, or publications that clearly describe the outbreak as a "pandemic." A Public Health Emergency of International Concern (PHEIC) alone will not qualify unless it is also described as a pandemic.
The primary resolution source for this market will be official WHO communications. A consensus of credible reporting may also be used.
Resolver
0x65070BE91...Hantavirus lacks the person-to-person transmission efficiency needed for pandemic spread, with CDC and WHO data showing primarily rodent-to-human spillover via aerosolized excreta and only rare, limited clusters from specific strains such as Andes virus. Current epidemiological surveillance through August 2026 reports no sustained chains or exponential case growth that would meet pandemic thresholds, supporting the 96.3% market-implied probability of "No." Trader consensus reflects this biological barrier alongside historical incidence patterns of sporadic, geographically contained infections. A realistic scenario that could shift odds involves an unexpected viral mutation enabling efficient human transmission, though surveillance data indicate such changes remain low-probability within the remaining months of 2026.
Polymarket डेटा का संदर्भ देने वाला प्रयोगात्मक AI-जनरेटेड सारांश। यह ट्रेडिंग सलाह नहीं है और इस बाज़ार के समाधान में कोई भूमिका नहीं निभाता। · अपडेट किया गया



बाहरी लिंक से सावधान रहें।
बाहरी लिंक से सावधान रहें।
अक्सर पूछे जाने वाले प्रश्न